Oncology FISH Analysis - CBFB: inv(16) [AML]
Use
Oncology FISH Analysis - CBFB: inv(16) [AML] is a specialized test designed to detect a chromosomal inversion commonly associated with acute myeloid leukemia (AML). AML is a serious leukemia predominantly affecting adults, originating from undifferentiated white blood cells in the bone marrow that can infiltrate various organs such as the liver, CNS, and lymph nodes. This FISH test primarily identifies the inv(16) or t(16;16) involving the CBFB gene, which correlates with favorable prognoses found in 5-8% of AML cases. Interpretation of results must be contextualized with clinical and pathological data, enhancing diagnostic accuracy in patients exhibiting symptoms or anomalies related to AML.
Special Instructions
This assay is implemented in various clinical situations, including when cytogenetic testing results are inconclusive, or for monitoring treatment responses. Proper specimen handling is essential to ensure the most accurate outcomes.
Limitations
This assay is limited to detecting specific rearrangements involving the CBFB locus. It cannot identify translocations involving other partner chromosomes, which may be crucial for comprehensive AML diagnostics. Results should supplement, rather than replace, other diagnostic approaches or tests, as they provide data specific only to the CBFB inversion and associated alterations.
Methodology
Chromosomal / Cytogenetics (FISH)
Biomarkers
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Bone Marrow (Fresh)
Volume
3-5 cc (Adults/Children), 2 cc (Infant< 2 years)
Minimum Volume
3 cc
Container
Sodium Heparin tube
Collection Instructions
Draw bone marrow in a Sodium Heparin (green-top) tube(s) and send.
Storage Instructions
Ship at ambient temperature (18-25°C/64-77°F) in an insulated container by overnight courier. Do not heat or freeze.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
